Skip to main content
Erschienen in: Quality of Life Research 2/2016

01.02.2016

Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer

verfasst von: Yu-Ling Chang, Yun-Fang Tsai, Yin-Kai Chao, Meng-Yu Wu

Erschienen in: Quality of Life Research | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Improving survival after esophagectomy is an important issue in treating patients with esophageal cancer (EC). In addition to standard hospitalization management, periodic assessment of quality-of-life (QOL) measures may be useful to detect disease progression from patients’ subjective reports. Therefore, this prospective longitudinal study was undertaken to identify prognostic factors for 3-year survival of EC patients after esophagectomy and to evaluate the impact of QOL measures on these prognostic factors.

Methods

Patients with EC (n = 67) who had a complete tumor resection and were alive 6 months after esophagectomy were followed in this study for 3 years. Data were collected on patients’ sociodemographics, cancer characteristics, adjuvant therapy, general QOL and EC-specific QOL (before esophagectomy and 6 months afterward), cancer recurrence, and death. Patients’ independent risk factors for 3-year survival were investigated by multivariate Cox regression analysis.

Results

Of the 67 participants with EC, 26 had late mortality, with a median survival for the whole cohort of 38.2 months (95 % CI 31.97–44.35). Independent predictors of early death were early cancer recurrence (within 6 months after surgery), poor cognitive function (95 % CI 1.020–1.041), and worse dyspnea (95 % CI 1.007–1.034).

Conclusions

The most predictive factor for early death in EC patients after esophagectomy was cancer recurrence within 6 months after surgery. However, QOL measures could be a tool to provide clinical information from patients’ perspective suggesting cancer recurrence.
Literatur
2.
Zurück zum Zitat Montgomery, E. A., Basman, F. T., Brennan, P., & Malekzadeh, R. (2014). Oesophageal cancer. In B. W. Stewart & C. P. Wild (Eds.), World cancer report 2014 (pp. 528–543). Geneva: World Health Organization. Montgomery, E. A., Basman, F. T., Brennan, P., & Malekzadeh, R. (2014). Oesophageal cancer. In B. W. Stewart & C. P. Wild (Eds.), World cancer report 2014 (pp. 528–543). Geneva: World Health Organization.
3.
Zurück zum Zitat Lu, C. L., Lang, H. C., Luo, J. C., Liu, C. C., Lin, H. C., Chang, F. Y., et al. (2010). Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes and Control, 21, 269–274. doi:10.1007/s10552-009-9458-0.CrossRefPubMed Lu, C. L., Lang, H. C., Luo, J. C., Liu, C. C., Lin, H. C., Chang, F. Y., et al. (2010). Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes and Control, 21, 269–274. doi:10.​1007/​s10552-009-9458-0.CrossRefPubMed
4.
Zurück zum Zitat Graham, A. J., Shrive, F. M., Ghali, W. A., Manns, B. J., Grondin, S. C., Finley, R. J., et al. (2007). Defining the optimal treatment of locally advanced esophageal cancer: A systematic review and decision analysis. Annals of Thoracic Surgery, 83, 1257–1264.CrossRefPubMed Graham, A. J., Shrive, F. M., Ghali, W. A., Manns, B. J., Grondin, S. C., Finley, R. J., et al. (2007). Defining the optimal treatment of locally advanced esophageal cancer: A systematic review and decision analysis. Annals of Thoracic Surgery, 83, 1257–1264.CrossRefPubMed
5.
Zurück zum Zitat Orringer, M. B., Marshall, B., Chang, A. C., Lee, J., Rickens, A., & Lau, C. L. (2007). Two thousand transhiatal esophagectomies. Annals of Surgery, 246, 363–374.PubMedCentralCrossRefPubMed Orringer, M. B., Marshall, B., Chang, A. C., Lee, J., Rickens, A., & Lau, C. L. (2007). Two thousand transhiatal esophagectomies. Annals of Surgery, 246, 363–374.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Reynolds, J. V., McLaughlin, R. J., Moore, S., Rowley, N. R., & Byrne, P. J. (2006). Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. British Journal of Surgery, 93, 1084–1090.CrossRefPubMed Reynolds, J. V., McLaughlin, R. J., Moore, S., Rowley, N. R., & Byrne, P. J. (2006). Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. British Journal of Surgery, 93, 1084–1090.CrossRefPubMed
7.
Zurück zum Zitat Safieddine, N., Xu, W., Quadri, S. M., Knox, J. J., Hornby, J., Sulman, J., et al. (2009). Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention. Journal of Thoracic Cardiovascular Surgery, 137, 36–42.CrossRefPubMed Safieddine, N., Xu, W., Quadri, S. M., Knox, J. J., Hornby, J., Sulman, J., et al. (2009). Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention. Journal of Thoracic Cardiovascular Surgery, 137, 36–42.CrossRefPubMed
8.
Zurück zum Zitat Davies, A. R., Pillai, A., Sinha, P., Sandhu, H., Adeniran, A., Mattsson, F., et al. (2014). Factors associated with early recurrence and death after esophagectomy for cancer. Journal of Surgical Oncology, 109, 459–464.CrossRefPubMed Davies, A. R., Pillai, A., Sinha, P., Sandhu, H., Adeniran, A., Mattsson, F., et al. (2014). Factors associated with early recurrence and death after esophagectomy for cancer. Journal of Surgical Oncology, 109, 459–464.CrossRefPubMed
9.
Zurück zum Zitat Kosugi, S. I., Kanda, T., Yajima, K., Ishikawa, T., & Hatakeyama, K. (2011). Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection. Annals of Surgical Oncology, 18, 2961–2967.CrossRefPubMed Kosugi, S. I., Kanda, T., Yajima, K., Ishikawa, T., & Hatakeyama, K. (2011). Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection. Annals of Surgical Oncology, 18, 2961–2967.CrossRefPubMed
10.
Zurück zum Zitat Mariette, C., Balon, J. M., Piessen, G., Fabre, S., Van Seuningen, I., & Triboulet, J. P. (2003). Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer, 97, 1616–1623. doi:10.1002/cncr.11228.CrossRefPubMed Mariette, C., Balon, J. M., Piessen, G., Fabre, S., Van Seuningen, I., & Triboulet, J. P. (2003). Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer, 97, 1616–1623. doi:10.​1002/​cncr.​11228.CrossRefPubMed
11.
Zurück zum Zitat Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2003). How quality of life data contribute to our understanding of cancer patients’ experiences? A study of patients with lung cancer. Quality of Life Research, 12, 157–166.CrossRefPubMed Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2003). How quality of life data contribute to our understanding of cancer patients’ experiences? A study of patients with lung cancer. Quality of Life Research, 12, 157–166.CrossRefPubMed
12.
Zurück zum Zitat Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., et al. (2009). Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncology, 10, 865–871. doi:10.1016/S1470-2045(09)70200-1.CrossRefPubMed Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., et al. (2009). Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncology, 10, 865–871. doi:10.​1016/​S1470-2045(09)70200-1.CrossRefPubMed
14.
Zurück zum Zitat Van Heijl, M., Sprangers, M. A. G., de Boer, A. G. E., Lagarde, S. M., Reitsma, H. B., Busch, O. R. C., et al. (2010). Preoperative and early postoperative quality of life predict survival in potentially curable patient with esophageal cancer. Annals of Surgical Oncology, 17, 23–30. doi:10.1245/s10434-009-0731-y.PubMedCentralCrossRefPubMed Van Heijl, M., Sprangers, M. A. G., de Boer, A. G. E., Lagarde, S. M., Reitsma, H. B., Busch, O. R. C., et al. (2010). Preoperative and early postoperative quality of life predict survival in potentially curable patient with esophageal cancer. Annals of Surgical Oncology, 17, 23–30. doi:10.​1245/​s10434-009-0731-y.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Grande, G. E., Farquhar, M. C., Barclay, S. I. G., & Todd, C. J. (2009). Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliative and Supportive Care, 7, 289–297.CrossRefPubMed Grande, G. E., Farquhar, M. C., Barclay, S. I. G., & Todd, C. J. (2009). Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliative and Supportive Care, 7, 289–297.CrossRefPubMed
16.
Zurück zum Zitat Djärv, T., & Lagergren, P. (2011). Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. European Journal of Cancer, 47, 530–535.CrossRefPubMed Djärv, T., & Lagergren, P. (2011). Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. European Journal of Cancer, 47, 530–535.CrossRefPubMed
17.
Zurück zum Zitat McKernan, M., McMillan, D. C., Anderson, J. R., Angerson, W. J., & Stuart, R. C. (2008). The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. British Journal of Cancer, 98, 888–893.PubMedCentralCrossRefPubMed McKernan, M., McMillan, D. C., Anderson, J. R., Angerson, W. J., & Stuart, R. C. (2008). The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. British Journal of Cancer, 98, 888–893.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Sundaram, A., Geronimo, J. C., Willer, B. L., Hoshino, M., Torgersen, Z., Juhasz, A., et al. (2012). Survival and quality of life after minimally invasive esophagectomy: A single-surgeon experience. Surgical Endoscopy, 26, 168–176.CrossRefPubMed Sundaram, A., Geronimo, J. C., Willer, B. L., Hoshino, M., Torgersen, Z., Juhasz, A., et al. (2012). Survival and quality of life after minimally invasive esophagectomy: A single-surgeon experience. Surgical Endoscopy, 26, 168–176.CrossRefPubMed
19.
Zurück zum Zitat Gillham, C. M., Aherne, N., Rowley, S., Moore, J., Hollywood, D., O’Byrne, K., et al. (2008). Quality of life and survival in patients treated with radical chemoradiation alone for oesophageal cancer. Clinical Oncology, 20, 227–233.CrossRefPubMed Gillham, C. M., Aherne, N., Rowley, S., Moore, J., Hollywood, D., O’Byrne, K., et al. (2008). Quality of life and survival in patients treated with radical chemoradiation alone for oesophageal cancer. Clinical Oncology, 20, 227–233.CrossRefPubMed
20.
Zurück zum Zitat Scarpa, M., Valente, S., Alfieri, R., Cagol, M., Diamantis, G., Ancona, E., et al. (2011). Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World Journal of Gastroenterology, 17, 4660–4674.PubMedCentralCrossRefPubMed Scarpa, M., Valente, S., Alfieri, R., Cagol, M., Diamantis, G., Ancona, E., et al. (2011). Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World Journal of Gastroenterology, 17, 4660–4674.PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Courrech Staal, E. F., van Sandick, J. W., van Tinteren, H., Cats, A., & Aaronson, N. K. (2010). Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment. Journal of Thoracic Cardiovascular Surgery, 140, 777–783. doi:10.1016/j.jtcvs.2010.05.018.CrossRefPubMed Courrech Staal, E. F., van Sandick, J. W., van Tinteren, H., Cats, A., & Aaronson, N. K. (2010). Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment. Journal of Thoracic Cardiovascular Surgery, 140, 777–783. doi:10.​1016/​j.​jtcvs.​2010.​05.​018.CrossRefPubMed
24.
Zurück zum Zitat Healy, L. A., Ryan, A. M., Moore, J., Rowley, S., Ravi, N., Byrne, P. J., et al. (2008). Health-related quality of life assessment at presentation may predict complications and early relapse in patient with localized cancer of the esophagus. Diseases of the Esophagus, 21, 522–528. doi:10.1111/j.1442-2050.2008.00814.x.CrossRefPubMed Healy, L. A., Ryan, A. M., Moore, J., Rowley, S., Ravi, N., Byrne, P. J., et al. (2008). Health-related quality of life assessment at presentation may predict complications and early relapse in patient with localized cancer of the esophagus. Diseases of the Esophagus, 21, 522–528. doi:10.​1111/​j.​1442-2050.​2008.​00814.​x.CrossRefPubMed
25.
Zurück zum Zitat American Joint Committee on Cancer. (2010). Cancer staging manual (7th ed., pp. 29–40). New York: Springer.CrossRef American Joint Committee on Cancer. (2010). Cancer staging manual (7th ed., pp. 29–40). New York: Springer.CrossRef
26.
Zurück zum Zitat Lerut, T., Moons, J., Coosemans, W., Van Raemdonck, D., De Leyn, P., Decaluwé, H., et al. (2009). Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence. Annals of Surgery, 250, 798–807. doi:10.1097/SLA.0b013e3181bdd5a8.CrossRefPubMed Lerut, T., Moons, J., Coosemans, W., Van Raemdonck, D., De Leyn, P., Decaluwé, H., et al. (2009). Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence. Annals of Surgery, 250, 798–807. doi:10.​1097/​SLA.​0b013e3181bdd5a8​.CrossRefPubMed
27.
Zurück zum Zitat Chie, W. C., Hong, R. L., Lai, C. C., Ting, L. L., & Hsu, M. M. (2003). Quality of Life in patients with nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQC30 and the EORTC QLQ-H&N35. Quality of Life Research, 12, 93–98.CrossRefPubMed Chie, W. C., Hong, R. L., Lai, C. C., Ting, L. L., & Hsu, M. M. (2003). Quality of Life in patients with nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQC30 and the EORTC QLQ-H&N35. Quality of Life Research, 12, 93–98.CrossRefPubMed
28.
Zurück zum Zitat Chie, W. C., Tsai, C. J., Chiang, C., & Lee, Y. C. (2010). Quality of life of patients with oesophageal cancer in Taiwan: Validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: A brief communication. Quality of Life Research, 19, 1127–1131.CrossRefPubMed Chie, W. C., Tsai, C. J., Chiang, C., & Lee, Y. C. (2010). Quality of life of patients with oesophageal cancer in Taiwan: Validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: A brief communication. Quality of Life Research, 19, 1127–1131.CrossRefPubMed
29.
Zurück zum Zitat Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). The EORTC QLQ-C30 scoring manual (3rd ed.). Brussels: European Organization for Research and Treatment of Cancer. Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). The EORTC QLQ-C30 scoring manual (3rd ed.). Brussels: European Organization for Research and Treatment of Cancer.
30.
Zurück zum Zitat Cox, D., & Oakes, D. (1984). Analysis of survival data. London: Chapman and Hall. Cox, D., & Oakes, D. (1984). Analysis of survival data. London: Chapman and Hall.
31.
Zurück zum Zitat Campbell, M. J. (2001). Statistics at square two: Understanding modern statistical applications in medicine. London: BMJ Books. Campbell, M. J. (2001). Statistics at square two: Understanding modern statistical applications in medicine. London: BMJ Books.
32.
Zurück zum Zitat Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., & Lanschot, J. J. B. (2010). Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World Journal of Surgery, 34, 2621–2627. doi:10.1007/s00268-010-0697-8.PubMedCentralCrossRefPubMed Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., & Lanschot, J. J. B. (2010). Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World Journal of Surgery, 34, 2621–2627. doi:10.​1007/​s00268-010-0697-8.PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Atkins, B. Z., Shah, A. S., Hutcheson, K. A., Mangum, J. H., Pappas, T. N., Harpole, D. H, Jr, et al. (2004). Reducing hospital morbidity and mortality following esophagectomy. Annals of Thoracic Surgery, 78(4), 1170–1176.CrossRefPubMed Atkins, B. Z., Shah, A. S., Hutcheson, K. A., Mangum, J. H., Pappas, T. N., Harpole, D. H, Jr, et al. (2004). Reducing hospital morbidity and mortality following esophagectomy. Annals of Thoracic Surgery, 78(4), 1170–1176.CrossRefPubMed
34.
Zurück zum Zitat Ancona, E., Cagol, M., Epifani, M., Cavallin, F., Zaninotto, G., Castoro, C., et al. (2006). Surgical complications do not affect long-term survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. Journal of the American College of Surgeons, 203(5), 661–669.CrossRefPubMed Ancona, E., Cagol, M., Epifani, M., Cavallin, F., Zaninotto, G., Castoro, C., et al. (2006). Surgical complications do not affect long-term survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. Journal of the American College of Surgeons, 203(5), 661–669.CrossRefPubMed
35.
Zurück zum Zitat Luc, G., Durand, M., Chiche, L., & Collet, D. (2015). Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus. World Journal of Surgery, 391, 216–222.CrossRef Luc, G., Durand, M., Chiche, L., & Collet, D. (2015). Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus. World Journal of Surgery, 391, 216–222.CrossRef
36.
Zurück zum Zitat Schieman, C., Wigle, D. A., & Deschamps, C. (2012). Patterns of operative mortality following esophagectomy. Diseases of the Esophagus, 25, 645.CrossRefPubMed Schieman, C., Wigle, D. A., & Deschamps, C. (2012). Patterns of operative mortality following esophagectomy. Diseases of the Esophagus, 25, 645.CrossRefPubMed
37.
Zurück zum Zitat Blazeby, J. M., Sanford, E., Falk, S. J., Aldersosn, D., & Donovan, J. L. (2005). Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer, 103, 1791–1799.CrossRefPubMed Blazeby, J. M., Sanford, E., Falk, S. J., Aldersosn, D., & Donovan, J. L. (2005). Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer, 103, 1791–1799.CrossRefPubMed
39.
Zurück zum Zitat Chou, Q., Hong, J., & Chou, P. (1997). Prevalence of cigarettes smoking and betel nut chewing in Taiwan. Chinese Journal of Dental Research, 16, 28–36. Chou, Q., Hong, J., & Chou, P. (1997). Prevalence of cigarettes smoking and betel nut chewing in Taiwan. Chinese Journal of Dental Research, 16, 28–36.
40.
Zurück zum Zitat Hwu, H. G., Yeh, E. K., Yeh, Y. L., & Chang, L. Y. (1988). Alcoholism by Chinese diagnostic interview schedule: A prevalence and validity study. Acta Psychiatrica Scandinavica, 77, 7–13.CrossRefPubMed Hwu, H. G., Yeh, E. K., Yeh, Y. L., & Chang, L. Y. (1988). Alcoholism by Chinese diagnostic interview schedule: A prevalence and validity study. Acta Psychiatrica Scandinavica, 77, 7–13.CrossRefPubMed
41.
Zurück zum Zitat Wu, I. C., Lu, C. Y., & Kuo, F. C. (2006). Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. European Journal of Clinical Investigation, 36, 236–241.CrossRefPubMed Wu, I. C., Lu, C. Y., & Kuo, F. C. (2006). Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. European Journal of Clinical Investigation, 36, 236–241.CrossRefPubMed
42.
Zurück zum Zitat Speicher, P. J., Englum, B. R., Ganapathi, A. M., Mulvihill, M. S., Hartwig, M. G., Onaitis, M. W., et al. (2015). Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. Journal of Thoracic Oncology, 10, 181–188.CrossRefPubMed Speicher, P. J., Englum, B. R., Ganapathi, A. M., Mulvihill, M. S., Hartwig, M. G., Onaitis, M. W., et al. (2015). Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. Journal of Thoracic Oncology, 10, 181–188.CrossRefPubMed
43.
Zurück zum Zitat Fang, F. M., Tsai, W. L., Chiu, H. C., Kuo, W. R., & Hsiung, C. Y. (2003). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 58(5), 1394–1404. doi:10.1016/j.ijrobp.2003.09.100.CrossRef Fang, F. M., Tsai, W. L., Chiu, H. C., Kuo, W. R., & Hsiung, C. Y. (2003). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 58(5), 1394–1404. doi:10.​1016/​j.​ijrobp.​2003.​09.​100.CrossRef
44.
Zurück zum Zitat Lou, F., Sima, C. S., Adusumilli, P. S., Bains, M. S., Sarkaria, I. S., Rusch, V. W., et al. (2013). Esophageal cancer recurrence patterns and implications for surveillance. Journal of Thoracic Oncology, 8, 1558–1562.PubMedCentralCrossRefPubMed Lou, F., Sima, C. S., Adusumilli, P. S., Bains, M. S., Sarkaria, I. S., Rusch, V. W., et al. (2013). Esophageal cancer recurrence patterns and implications for surveillance. Journal of Thoracic Oncology, 8, 1558–1562.PubMedCentralCrossRefPubMed
45.
Zurück zum Zitat Almhanna, K., Shridhar, R., & Meredith, K. L. (2013). Neoadjuvant or adjuvant therapy for resectable esophageal cancer: Is there a standard of care? Cancer Control, 20, 89–96.PubMed Almhanna, K., Shridhar, R., & Meredith, K. L. (2013). Neoadjuvant or adjuvant therapy for resectable esophageal cancer: Is there a standard of care? Cancer Control, 20, 89–96.PubMed
46.
Zurück zum Zitat Ku, G. Y., & Ilson, D. H. (2007). Esophageal cancer: Adjuvant therapy. Cancer Journal, 13, 162–167.CrossRef Ku, G. Y., & Ilson, D. H. (2007). Esophageal cancer: Adjuvant therapy. Cancer Journal, 13, 162–167.CrossRef
47.
Zurück zum Zitat Gysels, M., Bausewein, C., & Higginson, I. J. (2007). Experiences of breathlessness: A systematic review of the qualitative literature. Palliative and Supportive Care, 5, 281–302.CrossRefPubMed Gysels, M., Bausewein, C., & Higginson, I. J. (2007). Experiences of breathlessness: A systematic review of the qualitative literature. Palliative and Supportive Care, 5, 281–302.CrossRefPubMed
48.
Zurück zum Zitat Carrieri-Kohlman, V. (2006). Non-pharmacologic approaches. In S. Booth & D. Dudgeon (Eds.), Dyspnoea in advanced disease: A guide to clinical management (p. 171). New York: Oxford University Press. Carrieri-Kohlman, V. (2006). Non-pharmacologic approaches. In S. Booth & D. Dudgeon (Eds.), Dyspnoea in advanced disease: A guide to clinical management (p. 171). New York: Oxford University Press.
49.
Zurück zum Zitat Zhao, I., & Yates, P. (2008). Non-pharmacological interventions for breathlessness management in patients with lung cancer: A systematic review. Palliative Medicine, 22, 693–701.CrossRefPubMed Zhao, I., & Yates, P. (2008). Non-pharmacological interventions for breathlessness management in patients with lung cancer: A systematic review. Palliative Medicine, 22, 693–701.CrossRefPubMed
51.
Zurück zum Zitat Jim, H. S., Phillips, K. M., Chait, S., Faul, L. A., Popa, M. A., Lee, Y. H., et al. (2012). Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Journal of Clinical Oncology, 30, 3578–3587.PubMedCentralCrossRefPubMed Jim, H. S., Phillips, K. M., Chait, S., Faul, L. A., Popa, M. A., Lee, Y. H., et al. (2012). Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Journal of Clinical Oncology, 30, 3578–3587.PubMedCentralCrossRefPubMed
52.
Zurück zum Zitat Wefel, J. S., Collins, R., & Kayl, A. E. (2008). Cognitive dysfunction related to chemotherapy and biological response modifiers. In C. A. Myers & J. R. Perry (Eds.), Cognition and cancer (p. 97). Cambridge: Cambridge University Press.CrossRef Wefel, J. S., Collins, R., & Kayl, A. E. (2008). Cognitive dysfunction related to chemotherapy and biological response modifiers. In C. A. Myers & J. R. Perry (Eds.), Cognition and cancer (p. 97). Cambridge: Cambridge University Press.CrossRef
53.
Zurück zum Zitat Hurria, A., Somlo, G., & Ahles, T. (2007). Renaming “chemobrain”. Cancer Investigation, 25, 373–377.CrossRefPubMed Hurria, A., Somlo, G., & Ahles, T. (2007). Renaming “chemobrain”. Cancer Investigation, 25, 373–377.CrossRefPubMed
Metadaten
Titel
Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer
verfasst von
Yu-Ling Chang
Yun-Fang Tsai
Yin-Kai Chao
Meng-Yu Wu
Publikationsdatum
01.02.2016
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 2/2016
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1094-4

Weitere Artikel der Ausgabe 2/2016

Quality of Life Research 2/2016 Zur Ausgabe